OBJECTIVE: Compare levator ani cross-sectional area as a function of prolapse and muscle defect status. METHODS: Thirty women with prolapse and 30 women with normal pelvic support were selected from an ongoing case-control study of prolapse. For each of the two groups, 10 women were selected from three categories of levator defect severity: none, minor, and major identified on supine magnetic resonance scans. Using those scans, three-dimensional (3D) models of the levator ani muscles were made using a modeling program (3D Slicer), and cross-sections of the pubic portion were calculated perpendicular to the muscle fiber direction using another program, I-DEAS. An analysis of variance was performed. RESULTS: The ventral component of the levator muscle of women with major defects had a 36% smaller cross-sectional area, and women with minor defects had a 29% smaller cross-sectional area compared with the women with no defects (P < .001). In the dorsal component, there were significant differences in cross-sectional area according to defect status (P = .03); women with major levator defects had the largest cross-sectional area compared with the other defect groups. For each defect severity category (none, minor, major), there were no significant differences in cross-sectional area between women with and those without prolapse. CONCLUSION: Women with visible levator ani defects on magnetic resonance imaging had significantly smaller cross-sectional areas in the ventral component of the pubic portion of the muscle compared with women with intact muscles. Women with major levator ani defects had larger cross-sectional areas in the dorsal component than women with minor or no defects. LEVEL OF EVIDENCE: II-2.
OBJECTIVE: Compare levator ani cross-sectional area as a function of prolapse and muscle defect status. METHODS: Thirty women with prolapse and 30 women with normal pelvic support were selected from an ongoing case-control study of prolapse. For each of the two groups, 10 women were selected from three categories of levator defect severity: none, minor, and major identified on supine magnetic resonance scans. Using those scans, three-dimensional (3D) models of the levator ani muscles were made using a modeling program (3D Slicer), and cross-sections of the pubic portion were calculated perpendicular to the muscle fiber direction using another program, I-DEAS. An analysis of variance was performed. RESULTS: The ventral component of the levator muscle of women with major defects had a 36% smaller cross-sectional area, and women with minor defects had a 29% smaller cross-sectional area compared with the women with no defects (P < .001). In the dorsal component, there were significant differences in cross-sectional area according to defect status (P = .03); women with major levator defects had the largest cross-sectional area compared with the other defect groups. For each defect severity category (none, minor, major), there were no significant differences in cross-sectional area between women with and those without prolapse. CONCLUSION:Women with visible levator ani defects on magnetic resonance imaging had significantly smaller cross-sectional areas in the ventral component of the pubic portion of the muscle compared with women with intact muscles. Women with major levator ani defects had larger cross-sectional areas in the dorsal component than women with minor or no defects. LEVEL OF EVIDENCE: II-2.
Authors: John O L DeLancey; Helle Christina Sørensen; Christina Lewicky-Gaupp; Tovia M Smith Journal: Int Urogynecol J Date: 2011-08-06 Impact factor: 2.894
Authors: A Lenore Ackerman; Una J Lee; Forrest C Jellison; Nelly Tan; Maitraya Patel; Steven S Raman; Larissa V Rodriguez Journal: Int Urogynecol J Date: 2015-08-01 Impact factor: 2.894
Authors: Cornelia Betschart; Jinyong Kim; Janis M Miller; James A Ashton-Miller; John O L DeLancey Journal: Int Urogynecol J Date: 2014-05-15 Impact factor: 2.894
Authors: Linda Havelková; Ladislav Krofta; Petra Kochová; Václav Liška; Vladimír Kališ; Jaroslav Feyereisl Journal: Int Urogynecol J Date: 2019-06-13 Impact factor: 2.894
Authors: Ladislav Krofta; Linda Havelková; Iva Urbánková; Michal Krčmář; Luděk Hynčík; Jaroslav Feyereisl Journal: Int Urogynecol J Date: 2016-08-25 Impact factor: 2.894